[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 15, Issue 4 (Winter 2018) ::
Sci J Iran Blood Transfus Organ 2018, 15(4): 265-271 Back to browse issues page
A survey on causes of red blood cell alloimmunization in thalassemia patients in Shiraz, Iran
Leila Kasraian , Mojgan Shaiegan
Keywords: Key words: Thalassemia Major, Blood Transfusion, Red blood Cells, Screening
Full-Text [PDF 381 kb]   (880 Downloads)     |   Abstract (HTML)  (3485 Views)
Type of Study: Research | Subject: Imunohematology
Published: 2019/01/5
Full-Text:   (1498 Views)
References:
  1. Azarkeivan A, Ahmadi MH, Zolfaghari S, Shaiegan M, Ferdowsi S, Rezaei N, et al. RBC alloimmunization and double alloantibodies in thalassemic patients. Hematology 2015; 20(4): 223-7.
  2. Kiani A, Shirkhani Y, Kashi M, ABDI J. Prevalence of alloimmunization against RBC antigens in thalassemia major patients of Lorestan province in 1383. Sci J Iran Blood Transfus Organ 2006, 3(3): 265-71. [Article in Farsi]
  3. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37(1): 12-20.
  4. Cheng C, Lee C, Lin C. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012; 52(10): 2220-4.
  5. Koçyiğit C, Eliaçik K, Kanık A, Atabay B, Türker M. Frequency of red cell alio-and autoimmunization in patients with transfusion-dependent beta thalassemia and affecting factors. Turk J Pediatr 2014; 56(5): 487-92.
  6. Moghaddam M, Anaraki SZ, Shaiegan M, Azarkeivan A. Hyperhemolysis Syndrome in a Patient With B-Thalassemia Due to an Anti-Jka Alloantibody. J Hematol 2015; 4(3): 210-3.
  7. Keikhaei B, Hirad Far A, Abolghasemi H, Mousakhani H, Ghanavat M, Moghadam M, et al. Red Blood Cell Alloimmunization in Patients with Thalassemia Major and Intermediate in Southwest Iran. Iran J Blood Cancer 2013; 6(1): 41-6.
  8. Obaid JM, El-Nazar SYA, Ghanem AM, El-Hadidi AS, Mersal BH. Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt. Transfus Apher Sci 2015; 53(1): 52-7.
  9. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003; 43(11): 1604-10.
  10. El Danasoury AS, Eissa DG, Abdo RM, Elalfy MS. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 2012; 52(1): 43-7.
  11. Saied DA, Kaddah AM, Eldin RMB, Mohaseb SS. Alloimmunization and erythrocyte autoimmunization in  transfusion - dependent    Egyptian   thalassemic
 
 
 
 
patients. J Pediatr Hematol Oncol 2011; 33(6): 409-14.
  1. Iqbal I, Ahmed N. Frequency of red cell alloantibodies and auto antibodies in thalassemia major children. Biomedica 2014; 30(1): 25-8.
  2. Davari K, Soltanpour MS. Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients. Asian J Transfu Sci 2016; 10(1): 88-92.
  3. Dogra A, Sidhu M, Kapoor R, Kumar D. Study of red blood cell alloimmunization in multitransfused thalassemic children of Jammu region. Asian J Transfu Sci 2015; 9(1): 78-81.
  4. Rizzo C, Castiglia L, Arena E, Gangi S, Mazzola G, Caruso C, et al. Weak D and partial D: our experience in daily activity. Blood Transfus 2012; 10(2): 235-6.
  5. Economidou J, Constantoulakis M, Augoustaki O, Adinolfi M. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 1971; 20(3): 252-8.
  6. Osman NY, Bashir AI, Abdalla SE. Determination of allo-antibodies in Multiple Transfused Thalassemia, Sickle cell anemia and Hb C disease among Sudanese patients. NMJ 2013; 3(11): 14-23.
  7. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion - dependent thalassemia patients of predominantly Asian descent. Blood 2000; 96(10): 3369-73.
  8. Ho HK, Ha SY, Lam CK, Chan GC, Lee TL, Chiang AK, et al. Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood 2001; 97(12): 3999-4000.
  9. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. Non-transfusion-dependent thalassemias. Haematologica 2013; 98(6): 833-44.
  10. Noor Haslina MN, Ariffin N, Hayati II, Rosline H. Red cell immunization in multiply transfused Malay thalassemic patients. Southeast Asian J Trop Med Public Health 2006; 37(5): 1015-20.
  11. Thakral B, Saluja K, Sharma RR, Marwaha N. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology 2008; 13(5): 313-8.
  12. El Sewefy DA, Al Feky MA, Fatah MFA, El Sakhawy YN, Ragab IA, El Sayed HTN. Clinically significant red blood cell antibodies in multitransfused Egyptian thalassemic patients. Egypt J Haematol 2014; 39(3): 171-6.
 
 


 
 
 
 
Sci J Iran Blood Transfus Organ 2019; 15(4): 265-271
Original Article
 

 

A survey on causes of red blood cell alloimmunization
in thalassemia patients in Shiraz, Iran
 
Kasraian L.1,2, Shaiegan M.1
 
 
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Shiraz Blood Transfusion Center, Shiraz, Iran
 
 
 
Abstract
Background and Objectives
Estimation of the frequency and causes of immunization to red blood cells in transfusion dependent thalassemia (TDT) patients can help us know the limitations of current practice and plan   specific measures to reduce it. This study aimed to evaluate the frequency and causes of immunization in TDT patients.
 
Materials and Methods
This case control study was conducted on 732 (TDT) patients between 20 November 2015 to November 2016 in  Dastgheib Hospital, Shiraz, Iran. Direct coombs test, antibody screening, and antibody identification were performed for every TDT patient. Then, the  frequency  and type of antibodies were surveyed. Clinical and laboratory data of immunized and non-immunized patients were compared.
 
Results
All of the case group had positive results in direct or indirect coombs tests. Indirect coombs test (ICT) was positive in 59 patients (63.4%) while direct coombs tests (DCT) was positive in 41 (44%) of immunized patients. In addition, 7 patients (7.52%) showed positive results for both DCT and IAT. The most frequent antibodies were against Kell (48.6%), D (22.7%) and E (18.2%). Our results reflected that lower age of starting transfusion and splenectomy had an impact on higher immunization rate.  
 
Conclusions 
Antbodies against Rh and Kell system were the most frequent antibodies. It seems that extended RBC matching at least for ABO/Rh/Kell antigens must be performed for thalassemia patients with its effect on RBC immunization rate to be then surveyed.
 
Key words: Thalassemia Major, Blood Transfusion, Red Blood Cells, Screening
 
 
 
 
Received: 18 Apr 2018
Accepted:  6 Aug 2018
 
 

Correspondence: Kasraian L., Community Medicine Specialist. Associate Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine and Shiraz Regional Educational Blood Transfusion Center.
P.O.Box: 1153, Shiraz, Iran. Tel: (+98711) 6273445; Fax: (+98711) 6264006
E-mail:
lkasraian@yahoo.com
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kasraian L, Shaiegan M. A survey on causes of red blood cell alloimmunization in thalassemia patients in Shiraz, Iran. Sci J Iran Blood Transfus Organ 2018; 15 (4) :265-271
URL: http://bloodjournal.ir/article-1-1116-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 4 (Winter 2018) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4645